HighTower Advisors
PASG icon

HighTower Advisors’s Passage Bio PASG Stock Holding History

HighTower Advisors’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-917
Closed -$6.48K – 3921
2025
Q1 		$6.48K Buy
917
+141
+18% +$1.52K ﹤0.01% 3571
2024
Q4 		$8.8K Sell
776
-43
-5% -$560 ﹤0.01% 3590
2024
Q3 		$11K Sell
819
-257
-24% -$4.09K ﹤0.01% 3546
2024
Q2 		$17K Sell
1,076
-12
-1% -$294 ﹤0.01% 3408
2024
Q1 		$29K Sell
1,088
-25
-2% -$602 ﹤0.01% 3320
2023
Q4 		$23K Buy
1,113
+91
+9% +$1.26K ﹤0.01% 3388
2023
Q3 		$12K Sell
1,022
-944
-48% -$15.5K ﹤0.01% 3375
2023
Q2 		$30K Sell
1,966
-433
-18% -$8.57K ﹤0.01% 3219
2023
Q1 		$37K Buy
2,399
+257
+12% +$6.97K ﹤0.01% 3085
2022
Q4 		$50K Sell
2,142
-466
-18% -$11.8K ﹤0.01% 3034
2022
Q3 		$51K Sell
2,608
-141
-5% -$5.56K ﹤0.01% 2879
2022
Q2 		$124K Buy
2,749
+720
+35% +$33.6K ﹤0.01% 2745
2022
Q1 		$120K Buy
2,029
+620
+44% +$51.1K ﹤0.01% 2957
2021
Q4 		$187K Buy
1,409
+326
+30% +$53.2K ﹤0.01% 2799
2021
Q3 		$214K Buy
1,083
+413
+62% +$98.5K ﹤0.01% 2659
2021
Q2 		$178K Buy
+670
New +$207K ﹤0.01% 2696

Other funds holding PASG

NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HighTower Advisors's PASG Position: Q2 2025 in Review

HighTower Advisors sold out of Passage Bio (PASG) in Q2 2025, closing a stake of 917 shares — an estimated $6.48K sold.

HighTower Advisors first reported a position in PASG in Q2 2021 and held it in 16 quarters. The position peaked at $214K in Q3 2021. 39 funds tracked by Wall St. Rank hold PASG as of Q2 2025.

  • HighTower Advisors reported no remaining Passage Bio position as of Q2 2025 after selling out during the quarter.
  • HighTower Advisors sold 917 Passage Bio shares in Q2 2025, an estimated $6.48K.
  • HighTower Advisors first reported a position in Passage Bio in Q2 2021 and held it in 16 quarters.
  • HighTower Advisors's Passage Bio position peaked at $214K in Q3 2021.
  • 39 funds tracked by Wall St. Rank held Passage Bio as of Q2 2025.

Based on HighTower Advisors's 13F filing for Q2 2025, filed 11 Aug 2025.